Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging

Techniques in Coloproctology

Volumn 18, Issue 8, 2014, Pages 699-708

  Perez, R O ^a,b,d   Habr Gama, A ^a,b   Sao Juliao G P ^a   Lynn, P B ^a   Sabbagh, C ^a   Proscurshim, I ^a   Campos, F G ^b   Gama Rodrigues, J ^a,b   Nahas, S C ^b   Buchpiguel, C A ^b,c  

^a Angelita and Joaquim Gama Institute   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital do Coracao   (Brazil)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

Neoadjuvant chemoradiation; PET CT; Rectal cancer; Response assessment

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; RECTOSCOPY; RECTUM CANCER; ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FOLLOW UP; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECTAL NEOPLASMS; REPRODUCIBILITY; TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY, ADJUVANT; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84905912943     PISSN: 11236337     EISSN: 1128045X     Source Type: Journal    
DOI: 10.1007/s10151-013-1113-9     Document Type: Article

References (29)

1. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740
2. Sanghera P, Wong DW, McConkey CC, Geh JI, Hartley A (2008) Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response. Clin Oncol (R Coll Radiol) 20:176-183
3. Maas M, Nelemans PJ, Valentini V et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835-844
4. Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711-717 (discussion 717-718)
5. Smith FM, Waldron D, Winter DC (2010) Rectum-conserving surgery in the era of chemoradiotherapy. Br J Surg 97:1752-1764
6. Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J (2010) Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 53:1692-1698
7. Perez RO, Habr-Gama A, Gama-Rodrigues J et al (2011) Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683). Cancer 118:3501-3511
8. Perez RO, Habr-Gama A, Sao Juliao GP et al (2012) Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Int J Radiat Oncol Biol Phys 84:1159-1165
9. Habr-Gama A, Perez R, Proscurshim I, Gama-Rodrigues J (2010) Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer. Surg Oncol Clin N Am 19:829-845
10. Lambregts DM, Maas M, Bakers FC et al (2011) Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy. Dis Colon Rectum 54:1521-1528
11. Lambregts DM, Vandecaveye V, Barbaro B et al (2011) Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 18:2224-2231
12. Ichiya Y, Kuwabara Y, Otsuka M et al (1991) Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 32:1655-1660
13. Calvo FA, Domper M, Matute R et al (2004) 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58:528-535 (Pubitemid 38142480)
14. Martoni AA, Di Fabio F, Pinto C et al (2011) Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer. Ann Oncol 22:650-656
15. Konski A, Li T, Sigurdson E et al (2009) Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys 74:55-59
16. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 232:773-783 (Pubitemid 39100263)
17. Davey K, Heriot AG, Mackay J et al (2008) The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer. Dis Colon Rectum 51:997-1003
18. Vriens D, de Geus-Oei LF, van der Graaf WT, Oyen WJ (2009) Tailoring therapy in colorectal cancer by PET-CT. Q J Nucl Med Mol Imaging 53:224-244
19. Amthauer H, Denecke T, Rau B et al (2004) Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 31:811-819 (Pubitemid 38758350)
20. Guillem JG, Moore HG, Akhurst T et al (2004) Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg 199:1-7 (Pubitemid 38813288)
21. Melton GB, Lavely WC, Jacene HA et al (2007) Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg 11:961-969 (discussion 969)
22. Rosenberg R, Herrmann K, Gertler R et al (2009) The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis 24:191-200
23. Leibold T, Akhurst TJ, Chessin DB et al (2011) Evaluation of 18F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis. Ann Surg Oncol 18:2783-2789
24. Goldberg N, Kundel Y, Purim O et al (2012) Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study. Radiat Oncol 7:124
25. Lambrecht M, Deroose C, Roels S et al (2010) The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol 49:956-963
26. Capirci C, Rubello D, Pasini F et al (2009) The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Int J Radiat Oncol Biol Phys 74:1461-1469
27. Cascini GL, Avallone A, Delrio P et al (2006) 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47:1241-1248 (Pubitemid 47544874)
28. Habr-Gama A, Perez RO, Proscurshim I et al (2008) Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 71:1181-1188
29. Garcia-Aguilar J, Chen Z, Smith DD et al (2011) Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer. Ann Surg 254:486-492 (discussion 492-483)